Healthcare Leadership, Policy & Digital Health News IndiaHealthcare Leadership, Policy & Digital Health News IndiaHealthcare Leadership, Policy & Digital Health News India
  • Home
  • News
  • Articles
  • Exclusive
  • HB Originals
  • Gallery
  • Advertisement
Healthcare Leadership, Policy & Digital Health News IndiaHealthcare Leadership, Policy & Digital Health News India
  • Medical Science
Search
  • Home
  • Categories
    • Medical Science
    • Health Awareness
  • Bookmarks
  • More Foxiz
    • Sitemap
Follow US
  • Advertise
© 2025 Health Hub Media Pvt Ltd. All Rights Reserved.
Healthcare Leadership, Policy & Digital Health News India > Blog > Frontline Focus > After Eight Years of Persistence, Dr. Sivaranjani Santosh Forces FSSAI to Ban Misuse of “ORS” Label on Sugary Drinks

After Eight Years of Persistence, Dr. Sivaranjani Santosh Forces FSSAI to Ban Misuse of “ORS” Label on Sugary Drinks

Published: October 16, 2025
SHARE

Hyderabad paediatrician Dr. Sivaranjani Santosh’s long-running campaign against misleading marketing of sugary drinks as ORS has finally paid off: the FSSAI has ruled that only WHO-approved ORS formulae may use that label. This is a major win for child health, regulation, and consumer safety.

Glimpse:

For nearly eight years, Dr. Sivaranjani Santosh has been fighting to protect children and consumers from harmful products falsely labelled as oral rehydration salts (ORS). Beverage companies had been marketing high-sugar drinks under names like “ORS”, “ORSL”, or “ORS FIT”, wrongly implying they were medical rehydration solutions. Through legal action including a PIL in the Telangana High Court, public awareness campaigns, research and pressure on regulatory bodies, Dr. Santosh and her allies compelled the Food Safety and Standards Authority of India (FSSAI) to issue a directive (October 2025) banning the use of “ORS” on any product label, admission or advertising unless the formulation exactly matches WHO-prescribed electrolyte & glucose standards. The order withdraws earlier permissions that allowed use of “ORS” with disclaimers, strengthening consumer protection substantially.

They say persistence wins battles. Dr. Sivaranjani Santosh’s is a story that proves it. A paediatrician in Hyderabad, she noticed a troubling trend: children suffering from dehydration and diarrhoea were being given drinks labelled “ORS” by parents drinks whose composition was nothing like the WHO-approved formula. Some were sugary fruit-flavoured beverages with minimal electrolytes, misleading packaging, and marketing. These drinks weren’t just ineffective they could make things worse.

From about 2017 onward, Dr. Santosh began raising concerns. She documented cases, alerted child health forums, worked with fellow doctors, and pushed for regulatory clarity. In 2022, she filed a Public Interest Litigation in the Telangana High Court. She asked FSSAI, the Drugs & Cosmetics authorities, and the Union Health Ministry to step in and halt the misuse of the “ORS” label on beverages that fail to meet scientific standards.

There were partial victories and setbacks. In 2022, FSSAI issued a directive restricting misuse of “ORS”. But then came industry pressure: trademark-holders and manufacturers sought allowances to use the term as part of product names with disclaimers like “This is not the WHO ORS formula.” These loopholes weakened the impact. Dr. Santosh kept up public awareness videos, social media posts, op-eds calling out misleading packaging and the risk to child health sugar worsens diarrhoea, incorrect electrolyte balance is dangerous.

Finally, on October 14-15, 2025, FSSAI issued a sweeping order:

No beverage or food product can use the word “ORS” in its name, brand, trademark, packaging, or advertisement unless it strictly complies with the WHO-approved ORS formula (correct balance of salts, glucose etc.).

Previous permissions allowing “ORS” usage with disclaimers are revoked.

The regulator also clarified that products labelled with “ORS” but misaligned with the standard formula are misbranded and misleading, violating provisions of the Food Safety and Standards Act.

Dr. Santosh said after the order: “This victory belongs not to one person, but to people’s power, all the doctors, advocates, moms, and influencers who stood with me.” Her emotion reflected the years of effort and solidarity behind the scenes.

Highlighted Milestones in Her Eight-Year Battle:

YearKey Step / Event
2017Dr. Santosh starts noticing misleading “ORS”-labelled sugary drinks in pharmacies and clinics, raising alarms clinically.
2021Public awareness articles & medical interviews highlighting how popular “fruit ORS” drinks are too sweet, worsen diarrhoea. 
2022PIL filed in Telangana High Court; FSSAI issues first order restricting misleading ORS labels. But industry pushes back via trademark/disclaimer loopholes.
2024-2025Legal actions deepen, Endocrine Society joins, public debates sharpen, regulatory bodies pressured, awareness spreads among parents, doctors.
October 2025FSSAI issues final directive banning use of “ORS” label unless formula matches WHO standards, all disclaimers removed, prior relaxations revoked. Big regulatory win.

Importance & Impact:

Child Health Protection: Ensures that when parents see “ORS,” they get medical-grade rehydration, not sugary substitutes that can make dehydration worse.

Regulatory Clarity: Firm rules and legal backing now exist, closing loopholes exploited by manufacturers.

Public Awareness: The battle itself raised awareness about proper ORS usage, sugar content, and misleading labels.

Precedent for Consumer Safety: Sets an example for other labeling issues in food and health sectors  how vigilance can bring regulation.

Appreciation & Support from HealthBuzz:

On behalf of all of us at HealthBuzz, we salute Dr. Sivaranjani Santosh. This victory underscores what one committed individual, backed by clinical evidence, public health ethics, and community support, can achieve. We thank her for:

Clinical courage: confronting not corporations, but misinformation.

Advocacy & education: empowering parents, clinicians, and policy watchers to ask: “Is what I’m giving my child truly ORS?”

Persistence: eight years is a long battle filled with legal, scientific, and policy challenges.

Impacting policy: what might have seemed technical label wording, standards compliance is now life-saving regulation.

To all the doctors, NGOs, parents, moms, journalists, and influencers who stood with her  this win is yours, too. HealthBuzz is proud to amplify this milestone, and we pledge to continue reporting on enforcement, awareness, and ensuring that this regulation reaches every shop, pharmacy, and home across India.

“We have won the battle… The ORS tag must be reserved exclusively for WHO-compliant formulas. This decisive regulatory intervention will protect children.”

By

HB Team

Related News

Unihealth Expands African Footprint with Entebbe Deal, Boosts Capacity to 150 Beds

April 24, 2026

Graviti Pharma Expands South India Footprint with Strategic Karnataka Entry

April 24, 2026

Delhi Cantt Hospital Goes HighTech with Robotic Surgery Boost

April 24, 2026

Medtronic Brings Smart Brain Tech to India: A Game Changer for Parkinson’s Care

April 24, 2026

Premji Invest Backs Newera Hospitals to Expand Advanced Care Beyond Metro Cities

April 23, 2026

Venkaiah Naidu Unveils Atal MedTech Museum to Showcase India’s Healthcare Innovation Journey

April 23, 2026

Boehringer Ingelheim Launches £150M AI Hub in London to Accelerate Drug Discovery

April 23, 2026

Kotak Mahindra Bank Backs Advanced Diagnostics Upgrade at Mumbai’s Somaiya Hospital

April 23, 2026

Odisha Approves ₹3,877 Cr Investments to Accelerate Pharma and MedTech Growth

April 23, 2026

India Emerges as Global Leader in AI-Driven Healthcare Adoption

April 22, 2026

Aster CMI Introduces Karnataka’s First Dedicated Pediatric Liver ICU for Critical Care

April 22, 2026

India Launches First AI Driven Rural Medical Hub to Bridge Village Healthcare Gap

April 21, 2026

AI Meets Radiology at Scale: DeepTek and deepc Unite for Smarter Clinical Workflows

April 21, 2026

Apollo Hospitals Expands Tech-Driven Care to Sri City

April 21, 2026

Baptist Health Expands Rural Footprint with Magnolia Hospital Acquisition

April 19, 2026

New Leadership on the Horizon: CDC Eyes Stability with Erica Schwartz Nomination

April 21, 2026

eClinicalWorks CEO: Scaling AI Innovation in Healthcare Must Never Compromise Reliability or Safety

April 21, 2026

NHA Launches Digital Academy to Power India’s Next-Gen Healthcare Workforce

April 20, 2026

OpenAI Unveils GPT-Rosalind to Accelerate Drug Discovery and Life Sciences Research

April 20, 2026

Telemedicine in India: Key Rules Every Doctor Must Follow in the Digital Care Era

April 20, 2026
India and Seychelles Strengthen Healthcare & Pharma Ties Under New Sesel Joint Vision
Integris Medtech Eyes ₹3,500–4,000 Crore IPO as It Gears Up to Scale
Sakra IKOC Achieves Milestone with India’s First AI-Powered Total Knee Replacement Using Intellijoint System
Yogi Adityanath Courts Japanese Investors in Tokyo, Highlights YEIDA Medical Device Park
Patient Access Week 2026: Digital Health Tools Transforming the Front Door of Healthcare
Your browser does not support the audio element.
Your browser does not support the audio element.

Contact us

Privacy Policy

Terms & Conditions

HealthBuzz is a leading platform for healthcare news in India, covering hospital leadership updates, health policy developments, digital health innovations, and emerging healthcare startups. Stay informed with the latest insights shaping India’s healthcare ecosystem.

Facebook Twitter Youtube Whatsapp

Quick Links

  • Home
  • Articles
  • HB Originals
  • News
  • Videos
  • Gallery

Company

  • About us
  • Contact Us
  • Privacy Policy
  • Terms & Conditions
  • Content Complaince

Install our Mobile App for Best Experience

Healthcare Leadership, Policy & Digital Health News IndiaHealthcare Leadership, Policy & Digital Health News India
Follow US
Health Hub Media Pvt. Ltd. © 2026 All Rights Reserved
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?